Brand profile · Pharmaceutical Manufacturing

Rua Bioscience

Rua Bioscience runs a Pharmaceutical Manufacturing operation from Gisborne, Tairāwhiti. Ownership is privately held; it publishes at ruabio.com. It holds two addresses on record, all in New Zealand. The record counts 21 people. Tagged clinical trials, pharmaceuticals and intellectual property. The latest round on record is Grant at US$261.8K. The record links eight similar brands, most of them in Pharmaceutical Manufacturing.

Profile live Privately Held Founded 2017 1 office country US$ 261.8K Grant

Key facts

Counted staff
21
self-reported 11–50 band
Founded
2017
9 years
Legal entities
None matched
Office countries
1
2 addresses
Funding rounds
2
Grant · Aug 2021 · US$ 261.8K
Company type
Privately Held
self-reported
Use this profile Compare Your shortlist

Description

Rua is a Tairāwhiti based provider of medicinal cannabis products for local and export markets. Rua was founded in Ruatorea and remains focused on creating intergenerational social impact in Te Tairāwhiti.

Specialties

All 9 specialties
  • Medical Cannabis
  • Pharmaceuticals
  • Horticulture
  • Botanical Extractions
  • Exporting
  • Clinical Trials
  • Plant Breeding
  • Intellectual Property
  • Medicine Manufacturing

Related specialties

Locations

Country footprint

Offices in 1 countryCountry footprint: 1 country, primary NZ. Codes: NZ.1 countryprimary NZNZ
Show as table · Offices in 1 country
Offices in 1 country
Countries1
Primary countryNZ

All codes: NZ

Addresses

  • NZ1 Commerce Pl; Gisborne, Tairāwhiti 4071Primary
  • NZ704 Te Araroa Road; Ruatoria, Gisborne 4086

Grid intelligence Members

Funding

Last round · 1 August 2021US$ 261.8KGrant · investor: Callaghan Innovation
Rounds2
Round typeGrant · non-equity funding
Amount (USD)261,800
Stage rank1
Investors named1
Since last round4 yr 5 mo

Funding

2 funding roundsFunding timeline. Latest round 1 Aug 2021: Grant, US$ 261.8K.20172026GrantUS$ 261.8K2 rounds
Show as table · 2 funding rounds
2 funding rounds
Rounds2
Axis2017 to 2026
Grant · 1 Aug 2021US$ 261.8K

Dated rounds only. The axis ends at the date this profile was last observed, not at today.

Spending power

TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.

Spending power

Signals & hiring

Hiring, headcount and registry-change signals, streamed to members.

Latest signal
Hiring activity
Headcount trend

Financials

Registry-filed capital and financial indicators, standardised by TheGrid.

Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss

People & contacts

4 employee profiles on record · names withheld.

Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.

Counts only. No names are stored here, and none are served.

Notify me about contacts Tell us who you need to reach and we will tell you when a consented source is live.

FAQ

How many people work at Rua Bioscience?

The record holds 21 counted staff profiles at January 2026, inside the self-reported 11–50 band.

Where does Rua Bioscience have offices?

Two addresses on record, New Zealand only. Primary: 1 Commerce Pl, Gisborne, Tairāwhiti 4071.

Has Rua Bioscience raised funding?

Two rounds. Latest 1 August 2021: grant, US$261,800, investor Callaghan Innovation.

What does Rua Bioscience list as its specialties?

Nine tags on the brand's own list, among them clinical trials, pharmaceuticals and intellectual property.

Which companies are listed alongside Rua Bioscience?

33 profiles list Rua Bioscience as a peer — 97th percentile in Pharmaceutical Manufacturing. It lists ten peers of its own. Ora Pharm and Helius Therapeutics list it back.

What is Rua Bioscience's website?